1. What Sanofi might buy with its Regeneron windfall — Gilead pens $2B Arcus pact for immuno-oncology targets — FDA approves BMS Opdivo + Yervoy combo for first-line on certain types of NSCLC — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

I Miss Dura

Discussion in 'Dura' started by Anonymous, Mar 8, 2013 at 5:14 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    I want to go back to Dura so badly. The industry has gone to hell with all the guidelines and restrictions. It's just no fun anymore.

    I never thought I would miss the days of pulling up to a nasty, slimmy pay phone in the hood to listen to Walt Spath talkin Radio Dura but I do. Wow, those were good times and good people who wanted to work hard but have a lot of fun doing it.

    Oh well, back to all my reports and logging in my fake calls for the week.